Benzinga | Mar 30, 2021 04:18PM EDT

IGM Biosciences Q4 EPS $(0.79) Beats $(0.87) Estimate

IGM Biosciences (NASDAQ:IGMS) reported quarterly losses of $(0.79) per share which beat the analyst consensus estimate of $(0.87) by 9.2 percent. This is a 61.22 percent decrease over losses of $(0.49) per share from the same period last year.